Kwality Pharmaceuticals Ltd reports Q2FY27 revenue of ₹181.2 crore and raises FY27 revenue guidance to ₹720+ crore
- Q2 EBITDA was ₹49.8 crore (27.5% margin) and net profit ₹29.0 crore (16.0% margin); both rose 96% and 106% YoY, respectively.
- FY27 guidance: EBITDA of ₹189–196+ crore and PAT of ₹122+ crore.
- KPMG was appointed statutory auditor; no exceptional items were reported.
